Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd3603ae74db759ef3977bde2a41fd23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f78f54ca14939aa46c042b5f8098b330 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6544c7743aa5bb0d469f4985e801308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81dc85ff420b49c8023d870c9e4c42cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb0889b11725434cc12b485b460e8b49 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-01034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y205-01021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2013-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e3e657f80b8a434c8f93943acd72d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5061033ea69b0d9bba8ab03a0d5577d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15f95351cd8addee1233e2669afb27e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4def8f05a7693ab1aca0a402e3ad0d2c |
publicationDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013337459-A1 |
titleOfInvention |
A method of enhancing mir-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell |
abstract |
The present invention provides a method of quantifying miR-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating miR-185 in regulating LDL and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/LDL related cardiovascular diseases in humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616086-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016089390-A1 |
priorityDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |